Sonnet BioTherapeutics Holdings, Inc.Sonnet BioTherapeutics Holdings, Inc.Sonnet BioTherapeutics Holdings, Inc.

Sonnet BioTherapeutics Holdings, Inc.

No trades
See on Supercharts

Price target

12.500.00 0.00%
The 4 analysts offering 1 year price forecasts for SONN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to SONN in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

SONN EPS for the last quarter is −0.31 USD despite the estimation of −0.63 USD. In the next quarter EPS is expected to reach −0.70 USD. Track more of Sonnet BioTherapeutics Holdings, Inc. financials and stay on top of what is up with the company.
In the next quarter Sonnet BioTherapeutics Holdings, Inc. revenue is expected to reach ‪12.33 K‬ USD. Check out Sonnet BioTherapeutics Holdings, Inc. revenue and earnings and make informed decisions.
According to analysts, SONN price target is 12.50 USD with a max estimate of 30.00 USD and a min estimate of 2.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with SONN news and stock market news.